Sophia Garnette J.D.
Net Worth
Last updated:
What is Sophia Garnette J.D. net worth?
The estimated net worth of Ms. Sophia Garnette J.D. is at least $1,913,534 as of 4 Dec 2018. She owns shares worth $48 as insider, has earned $43,926 from insider trading and has received compensation worth at least $1,869,560 in International Stem Cell Corporation.
What is the salary of Sophia Garnette J.D.?
Ms. Sophia Garnette J.D. salary is $169,960 per year as Vice President of Legal Affairs & Operations, Principal Financial Officer and Sec. in International Stem Cell Corporation.
How old is Sophia Garnette J.D.?
Ms. Sophia Garnette J.D. is 41 years old, born in 1984.
What stocks does Sophia Garnette J.D. currently own?
As insider, Ms. Sophia Garnette J.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| International Stem Cell Corporation (ISCO) | Vice President of Legal Affairs & Operations, Principal Financial Officer and Sec. | 267 | $0.18 | $48 |
What does International Stem Cell Corporation do?
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; and develops, manufactures, and markets anti-aging skincare and human cell culture products. The company's human cell culture products include human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cells from the heart and blood vessels, and reagents to study cardiovascular disease and cancer; human bronchial and tracheal cell lines for the study of toxicity, cystic fibrosis, asthma, and pathogenesis; and human mammary epithelial cell lines for the study of breast cancer, three dimensional culture, and carcinogen screening. Its human cell culture products also comprise adult stem cells and reagents for regenerative medicine; human prostate cells and specialized medium to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; human female reproductive system cells for the study of cellular physiology; human skeletal muscle cells for the study of biology, diabetes, insulin receptor studies, muscle metabolism, muscle tissue repair, and myotube development; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. The company sells skincare products through a website and professional channels; and human cell culture products through its sales force, OEM partners, and brand distributors. International Stem Cell Corporation was founded in 2001 and is headquartered in San Diego, California.
Sophia Garnette J.D. insider trading
International Stem Cell Corporation
Ms. Sophia Garnette J.D. has made 8 insider trades between 2014-2018, according to the Form 4 filled with the SEC. Most recently she sold 10,636 units of ISCO stock worth $16,379 on 4 Dec 2018.
The largest trade she's ever made was exercising 10,636 units of ISCO stock on 4 Dec 2018. As of 4 Dec 2018 she still owns at least 267 units of ISCO stock.
International Stem Cell key executives
International Stem Cell Corporation executives and other stock owners filed with the SEC:
- Dr. Andrey Semechkin (65) Co-Chairman & Chief Executive Officer
- Dr. Russell Kern (39) Executive Vice President, Chief Scientific Officer & Director
- Ms. Sophia Garnette J.D. (41) Vice President of Legal Affairs & Operations, Principal Financial Officer and Sec.